
Ecogrel 2.5mg Tablet
Marketer
Delvin Formulations Pvt Ltd
Salt Composition
Prasugrel (2.5mg)
Overview Ecogrel 2.5mg Tablet
Cardiogard 2.5mg tablets are antiplatelet agents, also known as blood thinners. They function by inhibiting harmful clot formation, ensuring smooth blood flow. This reduces the risk of recurrent heart attacks or strokes in individuals with cardiac conditions. Cardiogard 2.5mg is indicated for patients recovering from a recent heart attack or experiencing severe angina pectoris, particularly those who've received coronary stenting. It helps prevent major cardiac events such as subsequent heart attacks, strokes, or stent thrombosis. This medication may be used concurrently with aspirin, another antiplatelet drug. It can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of wellness; discontinuation elevates the risk of cardiac events. The most prevalent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wounds may bleed excessively. While generally mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in patients with active internal bleeding (e.g., peptic ulcer, intracranial hemorrhage) or severe hepatic impairment. Prior to commencing therapy, inform your physician of any bleeding disorders, recent major trauma, or upcoming surgery. The medication may require temporary cessation prior to scheduled procedures.
Uses of Ecogrel 2.5mg Tablet
Avoiding heart attacks and strokes
Major Benefits of Ecogrel 2.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablets should be swallowed whole; avoid chewing, crushing, or breaking them. Ecogrel 2.5mg Tablets can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Ecogrel 2.5mg Tablet:
- Bleeding
How to use Ecogrel 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 2.5mg Ecogrel tablet whole; avoid crushing, chewing, or breaking it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Ecogrel 2.5mg Tablet works:
Platelet aggregation inhibitor Ecogrel, available in 2.5mg tablets, reduces the risk of recurrent stroke and myocardial infarction by inhibiting platelet adhesion, thus hindering clot development.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from taking Ecogrel 2.5mg Tablet concurrently with alcohol.
PregnancyCONSULT YOUR DOCTOR
Data on Ecogrel 2.5mg Tablet use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ecogrel 2.5mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ecogrel 2.5mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Ecogrel 2.5mg tablets in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Ecogrel 2.5mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data on Ecogrel 2.5mg tablet use in such patients is limited. Dosage alteration is not advised for individuals with mild to moderate liver dysfunction.
What if you forget to take Ecogrel 2.5mg Tablet :
Should you forget to take your Ecogrel 2.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ecogrel 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
